|
MD Anderson residual cancer burden score of excised primary malignant neoplasm of breast after neoadjuvant therapy (observable entity)
MD Anderson residual cancer burden score of excised primary malignant neoplasm of breast after neoadjuvant therapy
Residual cancer burden score of post-neoadjuvant breast neoplasms is a calculation of residual cancer based on the size of the viable neoplasm, cellularity of the neoplasm and lymph node involvement. The residual cancer burden class is based on this summative score.
Id1407078003
StatusPrimitive